Overview

Stanley B. Prusiner (born May 28, 1942) is an American neurologist and biochemist best known for proposing and developing the concept of the prion — a type of infectious agent composed primarily of protein. Prusiner's work reoriented thinking about certain neurodegenerative disorders and earned him the Nobel Prize in Physiology or Medicine in 1997. He is affiliated with the University of California, San Francisco, where he directs an institute focused on neurodegenerative disease research.

Prions and scientific contribution

Prusiner introduced the term prion (from "proteinaceous infectious particle") to describe agents that propagate by converting normal cellular proteins into abnormal conformations. This mechanism differs fundamentally from conventional pathogens because prions do not depend on nucleic acids to transmit disease. His laboratory characterized the prion protein (often abbreviated PrP) and showed how misfolded forms accumulate and damage brain tissue in affected animals and humans.

Historical development and reception

When first proposed, the prion hypothesis was controversial because it challenged the long-standing view that infectious agents require DNA or RNA. Over time, accumulating experimental evidence and the observation of similar phenomena across species — including scrapie in sheep, Creutzfeldt–Jakob disease in humans, and bovine spongiform encephalopathy in cattle — led to broad acceptance of prions as a distinct biological principle. Prusiner's persistence in pursuing biochemical and animal-model studies was central to that shift.

Impact, applications, and public health

The recognition of prion-mediated disease has had practical consequences for public health, blood and tissue safety, and sterilization practices. Understanding protein misfolding also influenced research into other neurodegenerative conditions in which abnormal protein aggregation plays a role, such as Alzheimer's and Parkinson's diseases. Prusiner's research helped open new avenues for diagnostics and for exploring therapeutic strategies that target abnormal proteins.

Honors and roles

  • Nobel Prize in Physiology or Medicine (1997) for the discovery of prions.
  • Recipient of major research awards recognizing contributions to basic medical science, including the Albert Lasker Award for Basic Medical Research.
  • Director of an institute at UCSF focused on neurodegenerative disease research; his professional profiles and institutional information are available through university pages such as faculty profiles and research summaries like department pages.

Notable facts and further reading

Prusiner's career bridges clinical neurology and basic biochemistry: his clinical perspective informed laboratory investigations into disease mechanisms. For introductions to prions, their biology, and implications for medicine and policy, consult accessible overviews and institutional resources such as research institute pages. The prion concept remains an important example of how a novel scientific idea can transform understanding of disease.